Cargando…

The Detrimental Effects of Alcohol and Cannabinoids on Cardiovascular Function

[Figure: see text]

Detalles Bibliográficos
Autores principales:	Montecucco, Fabrizio, Carbone, Federico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Editorial Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6872780/ https://www.ncbi.nlm.nih.gov/pubmed/31769444 http://dx.doi.org/10.1016/j.jacbts.2019.08.001

Ejemplares similares

Will it ever change? Lack of parental leave and its detrimental effects on maternal well-being
por: Jefferson, Erin E.Y.
Publicado: (2023)

Alleged Detrimental Mutations in the SMPD1 Gene in Patients with Niemann-Pick Disease
por: Rhein, Cosima, et al.
Publicado: (2015)

Arterial function and cardiovascular risk in dialysis
por: Iorio, Biagio R Di, et al.
Publicado: (2015)

The Detrimental Effects of Phthalates on Allergic Diseases
por: Ahn, Kangmo
Publicado: (2022)

Klotho: a link between cardiovascular and non-cardiovascular mortality
por: Lanzani, Chiara, et al.
Publicado: (2020)

Obesity phenotypes and cardiovascular risk: From pathophysiology to clinical management
por: Preda, Alberto, et al.
Publicado: (2023)

Statins; the panacea of cardiovascular disease
por: de Waard, G. A., et al.
Publicado: (2017)

Slicing Into Human Translational Cardiovascular Biology
por: Lavine, Kory J., et al.
Publicado: (2016)

Cardiovascular disease in older women with CKD
por: Radley, Alice, et al.
Publicado: (2023)

Cardiovascular dynamics in ischemic cardiomyopathy during exercise
por: van der Wall, E. E., et al.
Publicado: (2009)

Should ethnicity be included in cardiovascular risk stratification?
por: Krenning, B. J., et al.
Publicado: (2014)

Pokémon Go: cardiovascular benefit or injury risk?
por: Sharma, Pranev, et al.
Publicado: (2016)

Asynchronous Shortening of Telomere Length and Cardiovascular Outcomes
por: Wang, Chao-Yung
Publicado: (2018)

Cardiovascular changes in young renal failure patients
por: Tøndel, Camilla, et al.
Publicado: (2021)

Medicinal Cannabis and Synthetic Cannabinoid Use
por: Pichini, Simona, et al.
Publicado: (2020)

Gut Microbiota Manipulation to Mitigate the Detrimental Effects of Environmental Pollutants
por: Chen, Lianguo
Publicado: (2021)

Fingertip digital thermal monitoring: a fingerprint for cardiovascular disease?
por: van der Wall, E. E., et al.
Publicado: (2009)

The Time Is Now to Investigate Ventilator Settings in Acute Cardiovascular Patients
por: Miller, P. Elliott, et al.
Publicado: (2023)

The Role of the Intraplaque Vitamin D System in Atherogenesis
por: Carbone, Federico, et al.
Publicado: (2013)

Letter to the editor on “Geotemporospatial and causal inferential epidemiological overview and survey of USA cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003–2017, parts 1–3”
por: Chen, Frank Yizhao, et al.
Publicado: (2022)

Do We Understand Cardiovascular Issues in Children and Adolescents with Metabolic Syndrome?
por: Eun, Lucy Youngmin
Publicado: (2015)

Cardiovascular Benefits of GLP-1 Receptor Agonism: Is Inflammation a Key?
por: Marx, Nikolaus, et al.
Publicado: (2018)

Trimethylamine-N-Oxide: The Link Between Loop Diuretics and Cardiovascular Outcomes?
por: Adel, Fadi W., et al.
Publicado: (2021)

Cardiovascular disease and ANCA-associated vasculitis: are we missing a beat?
por: Floyd, Lauren, et al.
Publicado: (2022)

Are diabetes mellitus and lipoprotein(a) independently or causally associated with an increased cardiovascular risk?
por: Vavlukis, Marija
Publicado: (2017)

YKL-40 and its complex association with metabolic syndrome, obesity, and cardiovascular disease
por: Schernthaner, Gerit-Holger, et al.
Publicado: (2016)

Novel results and future perspectives of study of cardiovascular autonomic control in prediabetic patients
por: Kiselev, Anton R., et al.
Publicado: (2016)

Is there any relationship between cardiopulmonary capacity and cardiovascular mechanics in coronary artery disease?
por: Tadic, Marijana, et al.
Publicado: (2016)

Inflammatory Cardiovascular Risk Biomarkers: Update on Novelties and Limitations
por: Montecucco, Fabrizio, et al.
Publicado: (2012)

Synergistic and Detrimental Effects of Alcohol Intake on Progression of Liver Steatosis
por: Di Ciaula, Agostino, et al.
Publicado: (2022)

Commentary: Increased Risk of Cardiovascular Disease in Restless Legs Syndrome Patients: A Call to Action
por: De Berardis, Domenico, et al.
Publicado: (2023)

Cannabinoids and Cancer
por: Falasca, Marco, et al.
Publicado: (2021)

In the quest for treating alcohol liver disease
por: Ciocan, Dragos, et al.
Publicado: (2022)

Should UK Pneumococcal Vaccine Eligibility Criteria Include Alcohol Dependency in Areas with High Alcohol-Related Mortality?
por: Mooney, John D., et al.
Publicado: (2018)

Astrocytic TGF-β1: detrimental factor in ALS
por: Endo, Fumito, et al.
Publicado: (2015)

Tyrosine kinase inhibitor-induced hypertension—marker of anti-tumour treatment efficacy or cardiovascular risk factor?
por: Ptinopoulou, Anastasia G., et al.
Publicado: (2020)

A promising tool: triglyceride–glucose index to stratify the risk of cardiovascular events in chronic kidney disease
por: Yildirim, Fatma, et al.
Publicado: (2022)

Effects of Curcumin on Aging: Molecular Mechanisms and Experimental Evidence
por: Bahrami, Afsane, et al.
Publicado: (2021)

Alcohol-related harms and the certainty of deaths and taxes
por: Bhala, Neeraj B.
Publicado: (2022)

An Emerging Cardiovascular Disease: Takotsubo Syndrome
por: Moscatelli, Sara, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_r7uqbv6k3iofn72754rr41b8dn